Back to search results

Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Recurrent Glioblastoma or Recurrent Astrocytoma in Patients Undergoing Craniotomy

Abroad (travel likely)RecruitingPHASE1

Conditions

Recurrent Glioblastoma, IDH-Wildtype · Recurrent Astrocytoma, IDH-Mutant, Grade 4 · Astrocytoma, Grade IV

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Mayo Clinic in Florida, Jacksonville, Florida, United States

    Contact: Study coordinator (Clinical Trials Referral Office) · mayocliniccancerstudies@mayo.edu · 855-776-0015
    Contact: Principal Investigator (Alfredo Quinones-Hinojosa, MD)
Study leads

  • Alfredo Quinones-Hinojosa, MD

    Principal Investigator

    Mayo Clinic

View source on ClinicalTrials.gov(opens in a new tab)